Venous Thromboembolism and Bleeding after Transurethral Resection of the Prostate (TURP) in Patients with Preoperative Antithrombotic Therapy: A Single-Center Study from a Tertiary Hospital in China.
Zhongyi LiZhihuan ZhengXuesong LiuQuan ZhuKaixuan LiLi HuangZhao WangZheng-Yan TangPublished in: Journal of clinical medicine (2023)
Short-term preoperative discontinuation may help patients with antithrombotic therapy to obtain a relatively safe opportunity for TURP surgery after professional evaluation of perioperative conditions. The risks of perioperative bleeding, VTE, and serious cardiovascular and cerebrovascular complications are relatively controllable. It is essential for urologists to pay more attention to the perioperative management of these patients. However, further high-quality research results are needed for more powerful verification.
Keyphrases
- venous thromboembolism
- patients undergoing
- atrial fibrillation
- cardiac surgery
- end stage renal disease
- prostate cancer
- ejection fraction
- direct oral anticoagulants
- newly diagnosed
- minimally invasive
- benign prostatic hyperplasia
- peritoneal dialysis
- working memory
- coronary artery bypass
- acute kidney injury
- stem cells
- prognostic factors
- risk factors
- human health
- patient reported outcomes
- coronary artery disease
- risk assessment
- mesenchymal stem cells